Redhawk Wealth Advisors »

Halozyme Therapeutics shares owned by Redhawk Wealth Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Redhawk Wealth Advisors from 13F filings

Historical chart of Redhawk Wealth Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Redhawk Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Redhawk Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1M 37k 57.24
2024-06-30 $1.9M 36k 52.36

More positions owned by Redhawk Wealth Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Vanguard World Mega Cap Val Etf (MGV)
Spdr Gold Tr Gold Shs (GLD)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Capital Grp Fixed Incm Etf T Us Multi-sector (CGMS)
Apple (AAPL)
Ishares U S Etf Tr Int Rt Hdg C B (LQDH)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Select Sector Spdr Tr Technology (XLK)
J P Morgan Exchange Traded F Hedged Equity La (HELO)

View all positions for Redhawk Wealth Advisors

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics